{"id":507952,"date":"2021-06-29T18:38:02","date_gmt":"2021-06-29T22:38:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/"},"modified":"2021-06-29T18:38:02","modified_gmt":"2021-06-29T22:38:02","slug":"keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/","title":{"rendered":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement"},"content":{"rendered":"

<\/p>\n

Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement<\/b><\/p>\n

SEATTLE–(BUSINESS WIRE<\/a>)–
\nKeller Rohrback and co-counsel Longman Law, P.C. filed a class action lawsuit against Athira Pharma, Inc. (\u201cAthira\u201d) (NASDAQ: ATHA), certain of its officers and directors, and the underwriters of the IPO of Athira common stock. The suit, entitled Timothy Slyne, et al. v. Athira Pharma, Inc<\/i>., et al.<\/i>, was filed in the Western District of Washington on behalf of purchasers of ATHA common stock who either purchased shares in the September 2020 initial public offering (IPO) or on the open market that can be traced to the IPO. The lawsuit seeks remedies pursuant to the Securities Act of 1933.\n<\/p>\n

\nThe lawsuit alleges that Defendants misrepresented and omitted crucial truths regarding Athira Chief Executive Officer and President Dr. Leen Kawas in the Registration Statement for the IPO. Athira announced after close of trading on June 17, 2021 that the Athira Board placed Dr. Kawas on temporary leave in light of claims that she falsified research results in various academic papers. This news caused Athira\u2019s stock to plunge approximately 40% from $18.24 to $11.15 per share\u2014well below the $17.00 IPO price.\n<\/p>\n

\nAthira\u2019s misrepresentations about its President and CEO and omission regarding the alleged research misconduct caused injury to all those who purchased Athira common stock pursuant or traceable to the IPO. If you purchased or acquired ATHA common stock pursuant to or traceable to the IPO, please contact Keller Rohrback\u2019s securities team<\/a> at investor@kellerrohrback.com<\/a> or (800) 776-6044. <\/b><\/p>\n

\nNO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR\u2019S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS A LEAD PLAINTIFF.\n<\/p>\n

About Keller Rohrback L.L.P.<\/b><\/p>\n

\nWith offices in Seattle, Phoenix, New York, Oakland, Santa Barbara, and Missoula, Keller Rohrback serves as lead and co-lead counsel in class actions throughout the country. The firm has a track record for holding corporations accountable for wrongdoing and has achieved large settlements on behalf of its clients, including a $142 million settlement in the Wells Fargo Unauthorized Accounts Scandal.\n<\/p>\n

Attorney advertising. Prior results do not guarantee a similar outcome. This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and ethical rules. Please see krcomplexlit.com for more details.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210629006104\/en\/<\/a><\/span><\/p>\n

\nJuli Farris
\n
Keller Rohrback L.L.P.
\n
1201 Third Avenue, Suite 3200
\n
Seattle, WA 98101
\n
206-623-1900
\n
investor@kellerrohrback.com
\n<\/a>
www.krcomplexlit.com<\/a><\/p>\n

KEYWORDS:<\/b> Washington United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement SEATTLE–(BUSINESS WIRE)– Keller Rohrback and co-counsel Longman Law, P.C. filed a class action lawsuit against Athira Pharma, Inc. (\u201cAthira\u201d) (NASDAQ: ATHA), certain of its officers and directors, and the underwriters of the IPO of Athira common stock. The suit, entitled Timothy Slyne, et al. v. Athira Pharma, Inc., et al., was filed in the Western District of Washington on behalf of purchasers of ATHA common stock who either purchased shares in the September 2020 initial public offering (IPO) or on the open market that can be traced to the IPO. The lawsuit seeks remedies pursuant to the Securities Act of 1933. The lawsuit alleges that Defendants misrepresented … <\/p>\n

Continue reading “Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-507952","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKeller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement SEATTLE–(BUSINESS WIRE)– Keller Rohrback and co-counsel Longman Law, P.C. filed a class action lawsuit against Athira Pharma, Inc. (\u201cAthira\u201d) (NASDAQ: ATHA), certain of its officers and directors, and the underwriters of the IPO of Athira common stock. The suit, entitled Timothy Slyne, et al. v. Athira Pharma, Inc., et al., was filed in the Western District of Washington on behalf of purchasers of ATHA common stock who either purchased shares in the September 2020 initial public offering (IPO) or on the open market that can be traced to the IPO. The lawsuit seeks remedies pursuant to the Securities Act of 1933. The lawsuit alleges that Defendants misrepresented … Continue reading "Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-29T22:38:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement\",\"datePublished\":\"2021-06-29T22:38:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/\"},\"wordCount\":474,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/\",\"name\":\"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-06-29T22:38:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/","og_locale":"en_US","og_type":"article","og_title":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement - Market Newsdesk","og_description":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement SEATTLE–(BUSINESS WIRE)– Keller Rohrback and co-counsel Longman Law, P.C. filed a class action lawsuit against Athira Pharma, Inc. (\u201cAthira\u201d) (NASDAQ: ATHA), certain of its officers and directors, and the underwriters of the IPO of Athira common stock. The suit, entitled Timothy Slyne, et al. v. Athira Pharma, Inc., et al., was filed in the Western District of Washington on behalf of purchasers of ATHA common stock who either purchased shares in the September 2020 initial public offering (IPO) or on the open market that can be traced to the IPO. The lawsuit seeks remedies pursuant to the Securities Act of 1933. The lawsuit alleges that Defendants misrepresented … Continue reading \"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-29T22:38:02+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement","datePublished":"2021-06-29T22:38:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/"},"wordCount":474,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/","name":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-06-29T22:38:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210629006104r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keller-rohrback-files-suit-against-athira-pharma-for-misrepresentations-in-ipo-registration-statement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/507952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=507952"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/507952\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=507952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=507952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=507952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}